At present, the commonly used technique for infertility has a relatively low success rate of around 30 to 40 per cent. The prime reason for this is the process of selecting embryos for implantation in the mother’s womb depends only on morphology which is highly subjective. The two inventors of this non-invasive marker are claiming that their research will ensure a higher rate of success in such fertilization.
“We are experimenting with different molecules which are either released or taken up by the embryos using highly sensitive Nuclear Magnetic Resonance approach and we found that the uptake of pyruvate by the embryo and pyruvate/alanine ratio in the culture medium can serve as a potential biomarker in identifying the best embryos which can undergo implantation,”
The Department of Science and Technology, Government of India is supporting this study so that the IVF technology in India can experience a revolutionary change. Dr Guruprasad Kalthur (KMC), Shivananda Pudakalakatti (IISc), Shubhashree Uppangala (KMC) and Fiona D’Souza (KMC) are also involved in this study.
About the Company
Medi Connect India offers medical tourism services in India and connects to patient globally in helping them plan and research their medical travel in India. Medi Connect India is a division of Indian Holiday Private Limited ®, winners of 2 consecutive National Tourism Award and recognized by Ministry of Tourism, Government of India.